CLASS II ONGOING Device recall · Reported 24 Jul 2024 · FDA Enforcement Report

Unitrax Endoprosthesis Head Component recalled by Howmedica Osteonics

Howmedica Osteonics is recalling Unitrax Endoprosthesis Head Component - Implantable component used in partial hip, distributed nationwide in the US. The recall was initiated on 19 Jun 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN: 07613327032338 Lot Numbers: JT38AD, E94VEV
Quantity recalled12 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2372-2024
FDA event ID
94871
Recalling firm
Howmedica Osteonics, Mahwah, NJ
Classification
Class II
Status
Ongoing
Recall initiated
19 Jun 2024
FDA classified
16 Jul 2024
Reported
24 Jul 2024
Type
Voluntary: Firm initiated
Reason category
Labeling Errors

Timeline

19 Jun 2024Recall initiated by company
16 Jul 2024Classified by FDA+27 days
24 Jul 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Mislabeled: the size on the package label of the UNITRAX¿ Endoprosthesis Head Component potentially may not match the device within the packaging. This product mix only involves the three (3) sizes (43mm, 42mm, and the 38mm)

Product as listed by the FDA

UNITRAX Endoprosthesis Head Component - 38mm. Implantable component used in partial hip arthroplasty. Catalog Number: 6942-5-038

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Hong Kong, and UK.

Nationwide

Questions about this recall

Is Unitrax Endoprosthesis Head Component - Implantable component used in partial hip recalled?

Yes. Howmedica Osteonics recalled Unitrax Endoprosthesis Head Component - Implantable component used in partial hip on 19 Jun 2024. The recall is Class II and its status is Ongoing. Recall number Z-2372-2024.

Why was it recalled?

Mislabeled: the size on the package label of the UNITRAX¿ Endoprosthesis Head Component potentially may not match the device within the packaging. This product mix only involves the three (3) sizes (43mm, 42mm, and the 38mm)

Which lots are affected?

GTIN: 07613327032338 Lot Numbers: JT38AD, E94VEV

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Hong Kong, and UK.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Howmedica Osteonics

All 232

Other Hip & Knee Implants recalls

All 3,097